Eli Lilly and Company (LLY)’s Weight-Loss Pill Just Won Its First Race in Europe. Novo Nordisk A/S (NVO) Still Has a Head Start

Summary

Eli Lilly's weight-loss pill achieved its first regulatory approval in Europe, entering a competitive market dominated by Novo Nordisk's existing weight-loss treatments.